Showing results (111-120 of 313) with videos related to
Sort By:
Pageof 32
The Journal of Experimental Medicine|February 1, 1995
Human immunoglobulin (IgG) induced deletion of IgM rheumatoid factor B cells in transgenic miceH Tighe, P Heaphy, S Baird, et al.Arthritis and Rheumatism|September 1, 1978
Relative reactivities of rheumatoid factors in serum and cells. Evidence for a selective deficiency in serum rheumatoid factorD L Robbins, T L Moore, D A Carson, et al.Clinical Immunology and Immunopathology|October 1, 1985
Characterization of Epstein-Barr virus-specific T-cell hybridomas derived from infectious mononucleosisM A Valentine, C D Tsoukas, J H Vaughan, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1985
Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigenG Rhodes, D A Carson, J Valbracht, et al.Proceedings of the Association of American Physicians|July 1, 1996
Influence of the rheumatoid arthritis-associated shared epitope on T-cell receptor repertoire formationH Kohsaka, T Nanki, W E Ollier, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1984
Assignment of the gene for methylthioadenosine phosphorylase to human chromosome 9 by mouse-human somatic cell hybridizationC J Carrera, R L Eddy, T B Shows, et al.Journal of Medicinal Chemistry|November 1, 1986
9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)guanine: a metabolically stable cytotoxic analogue of 2'-deoxyguanosineJ A Montgomery, A T Shortnacy, D A Carson, et al.Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110J Roudier, J Petersen, G H Rhodes, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1979
Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell linesD A Carson, J Kaye, S Matsumoto, et al.European Journal of Immunology|December 18, 2001
Type I interferon is required to mount an adaptive response to immunostimulatory DNAJ H Van Uden, C H Tran, D A Carson, et al.Pageof 32